Latest News & Updates

Breaking News

1 day ago
Vaibhavi M.

George Medicines Appoints Brendan Walsh as SVP of Supply Chain and Technical Operations

Tonix Pharmaceuticals Enrolls First Patient in Phase 2 HORIZON Study of TNX-102 SL for MDD

Vaibhavi M.

Ipsen Acquires Kartos Therapeutics to Add Phase III MDM2 Inhibitor Navtemadlin to Oncology Pipeline

Simantini Singh Deo

Strides Pharma Divests Majority Stake in Pivot Path in Rs. 100 Crore Deal

Simantini Singh Deo

Roche Launches AXELIOS 1 Next-Generation Sequencing Platform Powered by Proprietary SBX Technology

Simantini Singh Deo

Other trending news you may like to read

George Medicines Appoints Brendan Walsh as SVP of Supply Chain and Technical Operations

George Medicines names Brendan Walsh SVP of Supply Chain to govern GMRx2's multi-CMO, eight-territory commercial network.

Vaibhavi M.

Tonix Pharmaceuticals Enrolls First Patient in Phase 2 HORIZON Study of TNX-102 SL for MDD

Tonix Pharmaceuticals enrolls first patient in HORIZON, a Phase 2 study of TNX-102 SL for MDD, extending its FDA-approved sublingual fibromyalgia tablet into a second indication.

Vaibhavi M.

Ipsen Acquires Kartos Therapeutics to Add Phase III MDM2 Inhibitor Navtemadlin to Oncology Pipeline

Ipsen acquires Kartos Therapeutics, adding Phase III MDM2 inhibitor navtemadlin with a potential 2028 approval target in myelofibrosis.

Simantini Singh Deo

Strides Pharma Divests Majority Stake in Pivot Path in Rs. 100 Crore Deal

Strides Pharma sells majority stake in Pivot Path for Rs. 100 crore, signalling portfolio consolidation toward regulated-market manufacturing.

Simantini Singh Deo